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Beneficial health properties of probiotics, prebiotics and other 
functional compounds strengthened the production, the offer and 
requirement of functional food products and/or pharmaceuticals 
worldwide. The efficacy of the administered functional products 
containing probiotic bacteria largely depends on the viability of the 
cells and their release in the lower intestine in sufficient number. 
Different techniques of microencapsulation have been used as a 
potential tool to enhance the viability of probiotics and to control 
release of these cells across the intestinal tract1,2. It is important the 
encapsulation method applied does not reduce viability of the cells 
and does not inhibit their activity which includes resistance of the 
cells to gastrointestinal environment and their ability to adhere to 
intestinal mucosa.  
Spray-drying is a method of microencapsulation where an aqueous 
solution containing the sensitive active core material and solution of 
wall material are atomized into hot air. The production of stable 
microparticles with low diameters and homogenous size distribution 
can be considered as advantage of the spray-drying method in 
comparison to extrusion or emulsion methods3,4. The main 
disadvantage of spray-drying technique is viability loss resulting 
from simultaneous dehydration and thermal inactivation of probiotic 
cells during the process5. Emulsion technique does not involve 
severe conditions, both in terms of temperature and solvents used, 
while has the benefit of producing very small (< 100 µm) 
microparticles6,7. Examples of biomaterials often applied to 
encapsulate bacterial cells include alginate, gelatin, chitosan, 
carrageenan, whey proteins, cellulose acetate phthalate, acacia 
gum, gellan and xanthan gum and starches1,2. Alginate beads are 
sensitive to the acidic environment, while cellulose acetate 
phthalate and mixture of gellan-xanthan are not soluble at acidic pH 
and enable high resistance towards acid conditions. Amphoteric 
nature of gelatin and whey protein allows favorable interaction with 
anionic polysaccharides when the pH is adjusted below the 
isoelectric point of the protein component thus the net charge of the 
protein becomes positive8. The behavior of the proteins below their 
isoelectric point encourages cooperation between proteins and 
polysaccharides in terms of higher survival rate of probiotics during 
processing and after consumption. Due to certain advantages and 
disadvantages of an applied method of encapsulation and coating 
agents, it is important to compare different biomaterials and 
encapsulation methods using the same probiotic strain. 
Lactobacillus casei is an acid sensitive, rod-shaped, facultative 
heterofermentative lactic acid bacterium that can be isolated from a 
variety of environments including raw and fermented milk and meat 
or plant products, as well as the oral, intestinal, and reproductive 
tracts of humans and animals. It is a beneficial microorganism that 
helps to promote other beneficial bacteria and prevents the 
overgrowth of pathogenic bacteria in the human body. It has been 
reported that it can improve and intensify digestion, control 
diarrhea, reduce inflammations of the gut, reduce lactose 
intolerance and alleviate the symptoms of constipation, all leading 
to better function of the immune system9,10. Recently, there has 
been intensive usage of this probiotic in functional food products. 
However, many reports indicate poor survival of the probiotic in 
these products and also the survival in the human gastrointestinal 
system is questionable11. In our preliminary studies, 3-hour 
exposure to simulated gastric acid at 37°C using a horizontal 
shaking water bath with 75 strikes/min (0.08 M HCl; 2 g/L NaCl; 3 
g/L pepsin; pH 1.5) resulted in poor survival of L. casei, 2.68±0.28 
log cfu/g vs. 10.51+0.58 log cfu/g as initial cell count, while with 10-
hour continuous exposition to bile salts in рН 6.8 (0.05 M KH2PO4; 
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Microencapsulation using two different methods, spray-drying and emulsion technique were applied to preserve 
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10 g/L bile salts), the viability of the probiotic decreased to 
4.18±0.13 log cfu/g12. Considering that, providing L. casei with a 
physical barrier against adverse environmental conditions could 
significantly improve its stability thus ensuring its health effects.   
The aim of this study was to evaluate the effects of coating 
materials and applied methods of encapsulation on the viability of 
probiotic strain Lactobacillus casei - 01 during preparation and 
storage of chitosan-Ca-alginate and whey protein-Ca-alginate 
microparticles. The probiotic whey protein-Ca-alginate 
microparticles were obtained using an emulsion method, while 
probiotic/synbiotic chitosan-Ca-alginate microparticles were 
prepared by spray-drying method. As the spray-drying method is 
associated with aggressive conditions of encapsulation, it is 
worthwhile to add prebiotic or other protective agent in the medium 
before drying. Thus, to improve the viability of probiotic L. casei 
during preparation and storage of the chitosan-Ca-alginate 
microparticles, the medium for spray-drying was supplemented with 
oligofructose enriched inulin (Synergy 1®) as prebiotic. Further, the 
viability of L. casei using different cryoprotective agents was 
determined and compared with L. casei loaded in whey protein-Ca-
alginate microparticles as control.  
 
2. MATERIALS AND METHODS 
 
2.1 Microencapsulation by spray-drying 
Probiotic/synbiotic chitosan-Ca-alginate microparticles were 
prepared by modified method of spray-drying13 that was previously 
successfully applied for microencapsulation of sensitive drug 5-
aminosalicylic acid14,15. The feed suspension was prepared of 
carrier agent sodium alginate (4% w/w) (Protanal LF 10/60 LS, fG 
35-45%, FMC BioPolymer, IMCD, Ayrshire, UK) and oligofructose 
enriched inulin (1.5% w/w) (Orafti® Synergy 1, Orafti-Rue L. 
Maréchal, Tienen, Belgium) which is the mixture of oligofructose 
(DP 2-8) and long-chain inulin fraction (DP 10-60). Then, overnight 
inoculated culture of Lactobacillus casei - 01 (Chr. Hansen, 
Hoersholm, Denmark) into MRS broth at 37 °C was added to 
alginate-prebiotic mixture. Alginate suspension enriched by 
prebiotic and probiotic L. casei with a cell load ca. 12 log cfu/g was 
infused into a spray-dryer (Büchi Mini Spray Dryer B-290, Flawil, 
Switzerland) at a constant air inlet temperature of 120 °C and outlet 
temperature at 58±3 °C. The flow rate of the spray-drying process 
was 6 ml/min, nozzle diameter 0.7 mm, aspirator pressure 90% and 
atomizer pressure 600 Nlh-1.  The dried powder samples were 
collected in sterile containers and then slowly added into previously 
prepared solution of 5% (w/w) CaCl2 (Merck, KGaA, Darmstadt, 
Germany) and 0.5% (w/w) chitosan (France Chitine, Marseille, 
France) in 1% (v/v) acetic acid under continuous stirring using a 
magnetic stirrer for at least 3 h at room temperature. The hardened 
microparticles were separated by centrifugation at 1500 x g for 10 
min, washed with sterile saline solution and frozen at -20 °C. 
Afterwards, the microparticles were freeze-dried at 0.070 mbar and 
-50 °C for 24 h (FreeZone Freeze Dry System, Labconco, Kansas 
City, USA).  
 
2.2 Microencapsulation by emulsion method 
For the preparation of probiotic whey protein-Ca-alginate 
microparticles, emulsion technique adapted from Mandal et al.16 
combined with subsequent coating according to the method 




. Namely, aqueous 
suspension of sodium alginate (2.5% w/w) and L. casei (cell load 
ca. 12 log cfu/g) was emulsified in olive oil (Sigma-Aldrich, St. 
Louis, USA) with 0.2% Tween 80 (Merck, KGaA, Darmstadt, 
Germany) while stirring magnetically. The emulsion droplets were 
hardened by quickly added CaCl2 and the mixture was allowed to 
stir for additional 15 min. The particles were removed from the 
aqueous phase by centrifuging at 1000 x g for 5 min and 
subsequently rinsed with sterile water until complete removal of the 
oil phase. Additional coating of the alginate particles was performed 
into 3% w/w native whey protein solution (100% Hydrolyzed whey 
protein isolate – ISO 100, Dymatize Nutrition, Farmers Branch, 
USA) by stirring at initial speed of 900 rpm to disperse the particles. 
After 60 min, the coated particles were separated by centrifugation 
at 1000 x g for 5 min, rinsed twice with sterile water, frozen at -20 
°C and freeze-dried at conditions given in the previous section. 
Further, the cryoprotective effects of oligofructose enriched inulin, 
sorbitol, sucrose and lactose during freeze-drying of L. casei loaded 
whey protein-Ca-alginate microparticles were investigated. Thus, 1 
ml of 10% (w/v) solution of tested cryoprotectants in phosphate 
buffered saline was mixed with 5 g of prepared microparticles 
before freeze-drying and cell viability determined after freeze-drying 
and 8-week of cold storage. 
 
2.3 Enumeration of encapsulated L. casei 
For quantitative determination of cell viability, it was necessary to 
release the encapsulated L. casei from the particles. Thus, one 
gram of particles was suspended in 9 ml phosphate buffer solution 
(pH 6.9) at room temperature until complete release of the probiotic 
cells. Measurements of viable cells in the suspensions were 
determined using plate-count method on selective MRS agar with 
incubation at 37 °C under aerobic conditions for 72 h. The average 
of the results obtained in triplicates was expressed as colony-
forming units per gram or ml of sample (cfu/g or cfu/ml) using 







Where, a is the number of colonies expressed as cfu/ml, an is the 
number of colonies determined at dilution n, V is the volume of the 
sample in ml and Cn is reciprocic value of the dilution n. Afterwards, 
results calculated in cfu/g were transformed to log cfu/g to make the 
reading of the paper more friendly. 
 
RESULTS AND DISCUSSION 
 
3.1 Viability of L. casei encapsulated by spray-drying versus 
emulsification 
Probiotic/synbiotic chitosan-Ca-alginate microparticles using a 
spray-drying method and probiotic whey protein-Ca-alginate 
microparticles using an emulsion method with high cell rate were 
produced. The encapsulation efficiency of the emulsion method 
applied was higher (95.8±0.7%) compared with the spray-drying 
method, 89.5±1.2. The increased efficiency of microencapsulation 
of the probiotic cells using an emulsion technique is probably due to 
the mild conditions of the procedure applied. Herewith, the 
reduction of the survival rate of encapsulated probiotic cells in whey 
protein-Ca-alginate microparticles was lower than it was in 
probiotic/synbiotic loaded chitosan-Ca-alginate microparticles 
before freeze-drying (Table 1), although, the medium intended for 
spray-drying was supplemented by prebiotics as inulin and 
oligofructose, which may be useful for enhancing probiotic viability 
during spray-drying and storage19.  
 
Table 1: Viability of L. casei during microencapsulation; (A) using 
spray-drying technique, biopolymers, alginate (4% w/w) and 
chitosan (0.5% w/w), CaCl2 (5% w/w) as cross-linking agent and 
oligofructose enriched inulin as prebiotic (1.5% w/w), and (B) using 
emulsification, encapsulating materials, alginate (2.5% w/w) and 
whey protein (3% w/w), and CaCl2 (3% w/w). 
 
Sample 




Viability of L. casei 
before coating by 
chitosan/whey 
proteins (log cfu/g) 
Viability of L. casei 
after freeze-drying 
(log cfu/g) 
A 12.52±0.15 11.84±0.11 11.28±0.26 
B 11.26±0.27 10.91±0.19 10.55±0.21 
 
Spray-drying process is advantageous in view of rapidity and 
relatively low cost20 as well high reproducibility and suitability for 
industrial applications1. However, high temperature and rapid 
evaporation of water during atomization of a suspension of 
probiotics and encapsulating agents in a drying chamber may 
destroy the integrity of the cell membrane provoking significant 
inactivation of the cells despite short residence time in the hot air 
drying chamber. Thus, the initial viability of L. casei in alginate 
suspension prepared for spray-drying was significantly higher in 
respect to the alginate bacterial suspension prepared to 
emulsifying. The concentration of sodium alginate as encapsulating 
agent applied in both methods used to encapsulate the probiotic L. 
casei is also different in accordance with our previous 
investigations. Namely, the optimization procedures using a full-
factorial experimental design have shown that the 
probiotic/synbiotic chitosan-Ca-alginate microparticles and probiotic 
whey protein-Ca-alginate microparticles with advanced 
physicochemical (particle size, zeta potential and Ca content) and 
enhanced functional properties (probiotic viability during 
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microencapsulation and in simulated gastrointestinal conditions) 
can be obtained when alginate at respective concentration of 4% 
w/w13 and 2.5% w/w12 was applied. 
 
3.2 Effects of protective polymers on viability of encapsulated 
L. casei 
Sodium alginate is often applied for encapsulation of probiotic cells 
due to its low cost, biocompatibility and suitability to form gels 
easily by selective binding of divalent ions, while properly resolve in 
the intestine and release entrapped cells. Alginate microparticles 
improved survival of L. casei NCDC-298 in simulated GI conditions 
and exposure to heat16 and had no negative effect on adhesion of 
probiotic cells to HT-29 cell line of the human epithelium21. 
However, alginate particles are sensitive to acid medium and they 
can be easily disintegrated in the presence of monovalent ions or 
salts as phosphates, lactates and citrates which bond calcium ions. 
Additional disadvantage of alginate particles is their porous 
surface22. On the other hand, the polyelectrolyte nature of alginate 
enables improving its properties as encapsulating agent by creating 
of electrostatic interaction with other polymers or by using additives 
to cause structural modifications of alginate23. Physical and 
chemical stability of negatively charged alginate particles may be 
improved when they are coated with chitosan due to the structure 
obtained by cross-linking of opposite charged polymers where 
disorientation of the calcium ions is not possible, even the particles 
are subjected to monovalent ions or antigelling agents. Chitosan-
alginate particles have more strength and possess increased 
resistance to environmental conditions24. There are studies 
indicating that high molecular chitosan creates particles with better 
mucoadhesive properties25 and improves the survival of probiotic 
cells under gastrointestinal conditions26,27.    
The protective properties of alginate may be enhanced through 
combination of proteins due to various functional groups and 
significant number of potential interactions. Electrostatic 
interactions between polysaccharides and proteins produce 
complex structures that can be resolved or precipitated depending 
on the polymer properties (cationic, anionic), pH, ionic strength and 
ratio polysaccharide/protein8. Physicochemical properties of the 
obtained microparticles (elasticity, swelling, resistance) using a 
combination of polysaccharide and protein mainly depend of the 
conditions of manufacture, thus convenient encapsulating matrix 
may be designed by optimizing the conditions. Whey proteins as 
biocompatible and biodegradable components are potential 
candidates to improve protective effects of alginate, especially 
synergizing the surface properties of whey proteins with 
stabilization properties of polysaccharides in water-oil-water and oil-
water-oil double emulsions28. Other studies have already shown 
whey protein as effective protectant of probiotic survival during 
exposure to simulated gastrointestinal fluids and characterize whey 
protein as suitable carrier of viable and active probiotic cells17,29-31. 
In our study, the loss of viable cell number of encapsulated L. casei 
was 0.36 log after freeze-drying of whey protein-alginate 
microparticles, while for chitosan-Ca-alginate microparticles it was 
0.56 log. The increased survival of L. casei during freeze-drying in 
presence of whey protein is probably due to increased stability of 
proteins compared to sugars at temperature of transition of ice to 
liquid form32.  
 
3.3 Cryoprotective effects of sugars during freeze-drying of 
encapsulated L. casei 
The study of Desmond et al.33 has showed better survival of L. 
paracasei during drying when mixture of reconstituted skim milk 
(10%) as protein matrix and acacia gum (10%) as sugar compound 
was applied. Thus, to investigate whether adding of sugars or 
polyhydric alcohol to proteins may increase survival of 
encapsulated L. casei, probiotic whey protein-alginate 
microparticles were supplemented by oligofructose enriched inulin, 
lactose, sucrose and sorbitol before freeze-drying. The 
experimental results of the viability of encapsulated L. casei during 
freeze-drying and subsequent storage at 4°C using oligofructose 
enriched inulin (OEI), sorbitol (SORB), lactose (LACT) and sucrose 
(SUCR) as protective agents, are shown in Fig. 1, with respect to 
the whey protein-alginate microparticles (WP-ALG) as control and 
chitosan-Ca-alginate microparticles loaded with L. casei and 
oligofructose enriched inulin (CTS-ALG-OEI). Survival of 
encapsulated L. casei during the freeze-drying process was similar 
for whey protein-alginate microparticles and for the three of the 
tested cryoprotective agents (oligofructose enriched inulin, lactose, 
and sucrose). Sorbitol showed lowest protection of encapsulated 
cells from drying injuries, although its penetrating effect as 
polyalcohol should be more efficient than the effect of non-
penetrating substances as oligosaccharides. During storage at 4°C, 
there was no significant difference observed either among the 
tested protective agents, or in comparison to the control. The 
addition of protective compounds as sucrose and trehalose and 
prebiotics as Raftilose® (fructooligosaccharides), Hi-maize®, and 
Raftiline® (inulin) maintains the viability of probiotics during 
dehydration and storage of freeze-dried yoghurt, although the 
viability was not significantly lower in the samples without added 
protectants34. These indicate that the tested prebiotics have no 
additional cryoprotective function, thus the use of prebiotics as 




Figure 1: Viability of encapsulated L. casei during freeze-drying 
(BFD - before freeze-drying and AFD - after freeze-drying) and 
subsequent cold storage for 2 months of microparticles obtained by 
spray-drying method (CTS-ALG-OEI) and emulsification (WP-ALG) 
and whey protein-Ca-alginate particles using protective agents, 
oligofructose enriched inulin (WP-ALG-OEI), sorbitol (WP-ALG-
SORB), lactose (WP-ALG-LACT), and sucrose (WP-ALG-SUCR). 
Values are presented as averages (n=3)±standard error. 
 
3.4 Comparative viability of encapsulated L. casei during 
storage 
In our study, to preserve the viability of L. casei using a spray-
drying technique, polyelectrolyte complexation between alginate 
and chitosan was used, while using an emulsion technique, an 
electrostatic interaction between alginate and whey protein was 
applied. During 8-week of cold storage, the reduction of viable cell 
number encapsulated in synbiotic chitosan-Ca-alginate 
microparticles and probiotic whey protein-alginate microparticles 
was similar. After 3 months of storage at 4°C, the viability of L. 
casei encapsulated by emulsifying method was significantly higher 
(for approximately 0.8 log) with respect to the viability of L. casei 
encapsulated by spray-drying, although the second method 
includes prebiotic during drying. This may be due to the more 
stressful conditions of the spray-drying process, but also owing to 
different properties of the encapsulating materials applied. 
Conjugates obtained between amino groups in proteins and the 
reducing-end carbonyl residues in saccharides, generally have 
superior surface stabilization properties, compare to their 
components before conjugation28. The high protective potential of 
whey proteins in a view of probiotic viability is probably due to their 
buffering capacity which provided good shielding for encapsulated 
L. casei against harsh conditions during drying and exposure to 
simulated gastrointestinal fluids. 
The synbiotic microparticles manufactured using a spray-drying 
method and probiotic whey protein-Ca-alginate microparticles 
produced using an emulsion method were able to preserve the 
therapeutic level of viable cells within 4 months (6.9±0.24 log cfu/g) 
and 6 months (6.95±0.18 log cfu/g) of refrigerated storage, 
respectively. The polyelectrolyte complex between alginate and 
chitosan cross-linked with calcium ions is relatively porous, while 
whey proteins create strength anchorage for the cells that are 
embedded into the protein milieu30, thus the cells may retain their 
stability longer. The comparative results of the applied methods and 
encapsulating materials with respect to tolerance of L. casei  during 
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processing and storage conditions presented in this study are very 
valuable, considering that previously published work never 
considered comparison of methods, using a same probiotic strain 
and literature is relatively poor with these type of data. 
In conclusion, synbiotic chitosan-Ca-alginate microparticles and L. 
casei loaded whey protein-alginate microparticles showed potential 
for further implementation as functional ingredients to manufacture 
probiotic and/or synbiotic products with prolonged expiry date 
considering the proposed level of viable cells in the commercial 
product at the end of the shelf-life to be at least 106 cfu/g or ml in 
order probiotics to achieve positive effects35.   
  
4. CONCLUSION 
The effective preservation of the probiotic cells applying spray-
drying and emulsion techniques as encapsulation methods and 
appropriate selection of coating materials provided the survival rate 
of microencapsulated L. casei in chitosan-Ca-alginate  
microparticles and whey protein-Ca-alginate microparticles to be 
above the therapeutic level within 4 and 6 months of cold storage, 
respectively. No further improvement in survival of encapsulated 
cells coated by whey protein was observed when cryoprotective 
agents were added to the formulation before freeze-drying. 
Nevertheless, both microparticulate formulations, the synbiotic 
chitosan-Ca-alginate microparticles and whey protein-Ca-alginate 
microparticles, are potential candidates to be further used as 
functional ingredients in pharmaceutical and food industry.  
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